$0.9700
-0.03-2.99%
At close: -
$0.9800
0.011.03%
After Hours: Dec 19, 4:25 PM EDT
Comments
Loading...
Akari Therapeutics (NASDAQ:AKTX) Stock, Earnings Estimates, EPS, And Revenue
Akari Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Nov 19
EPS
$0.000
Quarterly Revenue
$0K
Annual Revenue
(as of Sep 30)
(as of Sep 30)
–
Analyze the earnings history of Akari Therapeutics using advanced sorting and filters.
Data brought to you by Benzinga APIs
Akari Therapeutics (AKTX) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
Akari Therapeutics (AKTX) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Akari Therapeutics (NASDAQ:AKTX) reporting earnings?
Akari Therapeutics (AKTX) is scheduled to report earnings on February 15, 2025. The last reported earnings were for reported on November 19, 2024 for Q3.
What were the latest earnings per share (EPS) for Akari Therapeutics (NASDAQ:AKTX)?
The Actual EPS was $0.00, which hit the estimate of $0.00.
What were Akari Therapeutics’s (NASDAQ:AKTX) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.